| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-10 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-09 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |